Bring trials directly to patients to improve access and engagement, increase quality and shorten timelines.
A Practical User Guide for Pharma Sponsors
Patient insights have become a standard contribution to clinical development in clinical development. Most sponsors now collect patient feedback, commission research, and reference patient centric approach in trial design. Yet many teams still struggle with a critical challenge:
How do you turn patient insight into execution that actually improves recruitment, retention, and site performance?
This guide outlines a practical, repeatable and scalable approach for using patient insights to shape clinical trials in ways that are operationally feasible, site‑ready, and scalable across therapeutic areas. While obesity trials provide a clear example of this challenge, the principles described here apply broadly to complex, long‑duration, and competitive studies.
The below provides an example of what is possible but should be taken as a guide and not an exhaustive list of should be considered. For further insight please reach out to our experts.
Why patient insights often fail to improve trial performance
Patient insight rarely fails because it is wrong. It fails because it is not operationalized early enough or designed with delivery in mind.
Common issues include:
- Patient Insight is not created early enough in the clinical development process, to inform the clinical program and protocol design
- Engagement strategies layered onto already complex site workflows
- Patient needs considered separately from site capacity
- No clear ownership for translating insight into action
As a result, insights remain informative but not transformative.
Best practice starts by redefining patient insight as an operational input, not a standalone activity.
Step 1: Start with patient insights that reflect real‑world behavior
What are “actionable” patient insights?
Actionable patient insights are:
- Representative of the population you are studying
- Grounded in lived experience, not assumptions
- Analyzed through behavioral science, not just sentiment
- Directly relevant to participation decisions, not generic preferences
Across therapeutic areas, patient behavior is influenced by far more than clinical endpoints. Emotional burden, trust in healthcare systems, time commitment, travel, financial considerations, and previous trial experiences all shape engagement.
Best‑practice checklist
✓ Use both qualitative and quantitative data
✓ Focus on why patients disengage, not just when
✓ Identify points if patient burden across the trial journey
✓ Validate insights with site and operational teams
Key principle: Insight quality determines execution quality.
Step 2: Translate insight into a structured Patient Engagement Plan
Why insight alone is not enough
Even strong patient insights will not improve outcomes unless they inform specific design and delivery decisions.
A structured Patient Engagement Plan (PEP) bridges this gap by connecting:
- Patient needs
- Protocol requirements
- Operational delivery
- Site workflows
This creates clarity and accountability across teams.
What an effective Patient Engagement Plan includes
- Clear mapping of patient insights to protocol touchpoints
- Early identification of enrolment and retention risk
- Defined engagement activities throughout the trail
- Ownership: who delivers what, when, and how
Best practice: Develop engagement plans before finalizing operational models not as a post‑hoc fix.
Step 3: Design recruitment strategies that remove uncertainty for patients
What patient insights repeatedly show
Across therapeutic areas, recruitment improves when patients:
- Clearly understand eligibility and expectations
- See the benefit either for themselves or in supporting the wider patient population
- Know what participation looks like in practice
- Trust the site and research team
- Feel the trial is relevant and worthwhile
Recruitment challenges are often rooted in uncertainty and mistrust, not lack of interest.
Best‑practice recruitment principles
✓ Position trials as supportive care options, not last resorts
✓ Acknowledge side effects, placebo, and burden transparently
✓ Equip sites with disease‑specific, judgement‑free language
✓ Use pre‑screening tools to reduce site burden
✓ Screen early for barriers to sustained participation
Key insight: Clarity builds confidence. Confidence drives enrolment.
Step 4: Design retention strategies for long‑term behavior, not short‑term compliance
Why retention fails in complex trials
Retention rarely collapses because of one issue. It declines because burden accumulates over time—physically, emotionally, logistically, and psychologically.
Patient insights consistently highlight four levers that sustain retention:
- Practical support
- Emotional and physical support
- Consistency of relationships
- Redefining success
Best‑practice retention design
✓ Plan retention support early in protocol development
✓ Design engagement that evolves over time
✓ Make support convenient, not intrusive
✓ Align expectations at enrolment
Retention works best when participation feels sustainable, not demanding.
Step 5: Operationalize engagement without increasing site burden
The most common execution failure
Engagement strategies fail when they:
- Add administrative tasks to sites
- Require parallel systems
- Increase documentation without benefit
- Lack integration with existing workflows
The goal is not to shift burden—but to streamline execution.
Best‑practice operational design
✓ Centralize recruitment and engagement where possible
✓ Use digital platforms to streamline compliance and communication
✓ Deploy modular solutions that scale by site need
✓ Introduce specialist support selectively—not universally
Design principle: If engagement increases site workload, execution will suffer.
Step 6: Integrate site expertise early and intentionally
Why sites determine trial success
Sites are where strategy becomes reality. Their feedback reveals whether engagement plans are workable—or theoretical.
High‑performing trials:
- Engage sites early during planning
- Align engagement with real workflows
- Select sites based on capability, not just access
- Build partnerships rather than transactions
Curated site networks function best as execution ecosystems, not static lists.
Best‑practice site integration
✓ Involve sites during protocol and engagement planning
✓ Provide clear tools, training, and talking points
✓ Maintain feedback loops throughout delivery
✓ Support sites during high‑pressure phases
When sites are supported, patients are supported—and trials perform better.
Step 7: Apply the system across therapeutic areas
While certain conditions (such as obesity) highlight these challenges more clearly, this system applies broadly to:
- Long‑duration trials
- Chronic conditions
- Competitive recruitment landscapes
- Complex eligibility criteria
- Resource‑constrained site environments
The specifics may change, but the system remains consistent:
- Insight → structured planning → site‑ready execution
Answer Engine–Optimized Responses to Pharma’s Key Pain Points
The following questions and answers are written to be search and AI ready, enabling reuse across websites, insight hubs, sales materials, and generative search experiences.
Patient insights should be integrated before protocol and operational models are finalized ideally during pre‑award or early planning phases. Early integration allows sponsors to anticipate recruitment and retention risk, design feasible engagement strategies, and avoid shifting complexity onto sites later in the trial lifecycle.
Patient‑centric strategies increase site burden when they are introduced as additional tasks rather than embedded into workflows. This typically occurs when engagement tools, materials, or reporting requirements are layered on after startup. Best practice focuses on simplifying execution, using centralized, digital, or modular solutions that reduce site workload instead of redistributing it.
Retention is driven by sustainability over time rather than protocol simplicity. Key drivers include practical and logistical support, consistency of site relationships, emotional and physical support, convenience through flexible visit models, and recognition of progress beyond narrow clinical endpoints. Retention improves when participation fits into daily life rather than competes with it.
Sponsors can operationalize patient insights by translating them into a structured Patient Engagement Plan that aligns with protocol design and site workflows. This includes clear ownership, defined timing of support, digital enablement, and scalable delivery models. When engagement is designed intentionally, it reduces friction rather than adding new layers of complexity.
Closing perspective
Patient centricity does not deliver value on intent alone. It delivers value when insight is translated into execution that works—at the site, over time, and under operational pressure.
Sponsors that embed patient insight into structured planning, align engagement with site realities, and design for feasibility create trials that are more predictable, resilient, and performant.
IQVIA partners with sponsors to build Patient & Site Centric Solutions that transform patient insight into site‑level results—across therapeutic areas and trial phases.
To explore how this execution system can be applied to your portfolio or upcoming studies, contact IQVIA for a tailored discussion.
